Clinical trial
MOVIPREP® Versus PICOLAX® Pilot Study
NCT00312481 · Norgine, Industry · Completed
Key facts
| NCT number | NCT00312481 |
|---|---|
| Title | MOVIPREP® Versus PICOLAX® Pilot Study |
| Official title | A Randomised, Single-Centre, Parallel-Group, Pilot Study to Assess the Efficacy, Safety and Patient Acceptability of a New 2-Litre Bowel Preparation Agent (MOVIPREP®) Compared With a Standard Bowel Preparation Agent (PICOLAX®) |
| Lead sponsor | Norgine, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colonoscopy |
| Intervention type | Drug |
| Interventions | macrogol3350 NA sulphate NACL KCL ascorbic acid NA ascorbate, NA picosulfate magnesium citrate |
| Enrollment | 65 |
| Start date | Jul 1, 2005 |
| Completion | May 1, 2006 |
| First posted | Apr 10, 2006 |
| Last update posted | Dec 17, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: